- Home
- ESS vs ELAN Comparison
ESS vs ELAN Comparison
Compare ESS & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ESS | ELAN |
|---|---|---|
| Founded | 1971 | 1954 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.5B | 12.7B |
| IPO Year | 1996 | 2018 |
Fundamental Metrics
Financial Performance| Metric | ESS | ELAN |
|---|---|---|
| Price | $243.18 | $24.06 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 16 | 9 |
| Target Price | ★ $282.30 | $27.63 |
| AVG Volume (30 Days) | 421.2K | ★ 4.8M |
| Earning Date | 04-28-2026 | 05-06-2026 |
| Dividend Yield | ★ 4.24% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 10.40 | N/A |
| Revenue | $1,887,345,000.00 | ★ $4,715,000,000.00 |
| Revenue This Year | $1.99 | $8.61 |
| Revenue Next Year | $3.39 | $4.90 |
| P/E Ratio | $23.35 | ★ N/A |
| Revenue Growth | ★ 6.36 | 6.22 |
| 52 Week Low | $238.46 | $8.02 |
| 52 Week High | $308.52 | $27.72 |
Technical Indicators
Market Signals| Indicator | ESS | ELAN |
|---|---|---|
| Relative Strength Index (RSI) | 41.56 | 48.47 |
| Support Level | N/A | $23.72 |
| Resistance Level | $263.53 | $25.64 |
| Average True Range (ATR) | 4.89 | 1.05 |
| MACD | -0.50 | -0.05 |
| Stochastic Oscillator | 28.31 | 51.38 |
Price Performance
Historical ComparisonAbout ESS Essex Property Trust Inc.
Essex Property Trust owns a portfolio of 259 apartment communities with over 63,000 units. The company focuses on owning large, high-quality properties on the West Coast in the urban and suburban submarkets of Southern California, Northern California, and Seattle.
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.